LivePerson Valuation

Is LPSN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LPSN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate LPSN's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate LPSN's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for LPSN?

Key metric: As LPSN is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for LPSN. This is calculated by dividing LPSN's market cap by their current revenue.
What is LPSN's PS Ratio?
PS Ratio0.2x
SalesUS$334.74m
Market CapUS$76.24m

Price to Sales Ratio vs Peers

How does LPSN's PS Ratio compare to its peers?

The above table shows the PS ratio for LPSN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average9.8x
UPLD Upland Software
0.4x-3.8%US$87.3m
WCT Wellchange Holdings
28.4xn/aUS$67.8m
SNCR Synchronoss Technologies
0.6x5.2%US$93.2m
VEEA Veea
10xn/aUS$85.7m
LPSN LivePerson
0.2x-11.0%US$76.2m

Price-To-Sales vs Peers: LPSN is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (9.8x).


Price to Sales Ratio vs Industry

How does LPSN's PS Ratio compare vs other companies in the US Software Industry?

81 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.5.1x12.3%
LPSN LivePerson
0.2x-11.0%US$76.24m
VYX NCR Voyix
0.6x-23.2%US$2.04b
PGY Pagaya Technologies
0.7x15.8%US$634.91m
LPSN 0.2xIndustry Avg. 5.1xNo. of Companies81PS048121620+
81 CompaniesEstimated GrowthMarket Cap
Industry Avg.5.1x17.3%
LPSN LivePerson
0.2x-26.9%US$76.24m
No more companies

Price-To-Sales vs Industry: LPSN is good value based on its Price-To-Sales Ratio (0.2x) compared to the US Software industry average (5.1x).


Price to Sales Ratio vs Fair Ratio

What is LPSN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LPSN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio0.7x

Price-To-Sales vs Fair Ratio: LPSN is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LPSN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$0.84
US$0.96
+14.4%
6.7%US$1.00US$0.85n/a4
Nov ’25US$1.20
US$1.10
-8.3%
15.7%US$1.40US$1.00n/a4
Oct ’25US$1.12
US$1.08
-3.6%
14.8%US$1.40US$1.00n/a5
Sep ’25US$1.23
US$1.08
-12.2%
14.8%US$1.40US$1.00n/a5
Aug ’25US$1.14
US$0.98
-13.7%
26.5%US$1.40US$0.50n/a6
Jul ’25US$0.58
US$0.92
+56.7%
25.7%US$1.25US$0.50n/a6
Jun ’25US$0.69
US$0.92
+33.5%
25.7%US$1.25US$0.50n/a6
May ’25US$0.51
US$1.75
+244.8%
39.6%US$3.00US$1.00n/a6
Apr ’25US$0.98
US$2.08
+112.4%
35.1%US$3.00US$1.00n/a6
Mar ’25US$1.30
US$2.14
+64.8%
27.1%US$3.00US$1.50n/a7
Feb ’25US$2.64
US$4.25
+61.0%
34.6%US$7.00US$3.00n/a7
Jan ’25US$3.79
US$4.25
+12.1%
34.6%US$7.00US$3.00n/a7
Dec ’24US$3.16
US$4.25
+34.5%
34.6%US$7.00US$3.00n/a7
Nov ’24US$2.60
US$5.14
+97.8%
21.9%US$7.00US$4.00US$1.207
Oct ’24US$3.89
US$5.43
+39.6%
16.6%US$7.00US$4.00US$1.127
Sep ’24US$4.13
US$5.38
+30.1%
15.9%US$7.00US$4.00US$1.238
Aug ’24US$4.61
US$5.25
+13.9%
12.6%US$6.00US$4.00US$1.148
Jul ’24US$4.52
US$4.72
+4.4%
17.5%US$6.00US$3.00US$0.588
Jun ’24US$3.58
US$4.72
+31.8%
17.5%US$6.00US$3.00US$0.698
May ’24US$4.68
US$5.38
+14.9%
18.5%US$7.00US$4.00US$0.518
Apr ’24US$4.41
US$5.38
+21.9%
18.5%US$7.00US$4.00US$0.988
Mar ’24US$9.49
US$13.20
+39.1%
33.0%US$25.00US$8.00US$1.3010
Feb ’24US$15.71
US$13.20
-16.0%
33.0%US$25.00US$8.00US$2.6410
Jan ’24US$10.14
US$13.45
+32.6%
31.9%US$25.00US$8.00US$3.7910
Dec ’23US$12.98
US$13.45
+3.6%
31.9%US$25.00US$8.00US$3.1610
Nov ’23US$10.60
US$14.70
+38.7%
28.4%US$25.00US$8.00US$2.6010

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies